Background
Methods
Diabetes screening
Questionnaire measurements
Statistical analysis
Results
Baseline characteristics | Invited (n = 116) | Non-invited (n = 238) |
---|---|---|
Age (years) | 58.3 (7.3) | 58.9 (7.2) |
Sex (number (%) male) | 76 (65.5%) | 149 (62.6%) |
BMI (kg/m2) | 31.8 (4.5) | 31.3 (4.1) |
Number (%) prescribed anti-hypertensive medication | 42 (36.2%) | 91 (38.2%) |
Number (%) prescribed steroid medication | 10 (8.6%) | 6 (2.5%) |
Screening uptake
Glucose testing (Figure 1)
Psychological outcomes
Invited (n = 77)* | Non-invited (n = 168)* | p-value from t-test | |
---|---|---|---|
STAI anxiety (range 20–80) | 37.6 (12.2) | 34.1 (12.1) | 0.015 |
Self-perceived health; range (1 to 5)** | 2.97 (0.86) | 2.95 (0.87) | 0.82 |
Illness representation subscales; (range 1 to 5) | |||
- Acute/chronic illness | 3.95 (0.48) | 4.07 (0.46) | 0.07 |
- Cyclic illness | 2.99 (0.42) | 2.93 (0.46) | 0.64 |
- Consequences | 3.25 (0.47) | 3.40 (0.50) | 0.08 |
- Personal consequences | 3.67 (0.44) | 3.70 (0.45) | 0.60 |
- Treatment control | 3.60 (0.41) | 3.60 (0.43) | 0.87 |
- Emotional representations | 2.58 (0.66) | 2.63 (0.75) | 0.74 |
- Illness coherence | 3.10 (0.83) | 3.05 (0.86) | 0.98 |
Attenders (n = 64)* | Non-attenders (n = 13)* | p-value from t-test | |
---|---|---|---|
STAI anxiety (range 20–80) | 37.3 (10.9) | 39.2 (17.8) | 0.77 |
Self-perceived health; range (1 to 5)** | 2.92 (0.86) | 3.23 (0.83) | 0.24 |
Illness representation subscales; (range 1 to 5) | |||
- Acute/chronic illness | 3.95 (0.48) | 3.94 (0.47) | 0.90 |
- Cyclic illness | 2.98 (0.41) | 3.07 (0.49) | 0.90 |
- Consequences | 3.28 (0.47) | 3.09 (0.43) | 0.22 |
- Personal consequences | 3.66 (0.43) | 3.74 (0.55) | 0.74 |
- Treatment control | 3.56 (0.41) | 3.87 (0.23) | 0.016 |
- Emotional representations | 2.68 (0.61) | 1.81 (0.45) | 0.001 |
- Illness coherence | 3.07 (0.84) | 3.29 (0.81) | 0.35 |